Amyotrophic Lateral Sclerosis Awareness Month; designating as May 2025 and in each succeeding year.
Summary
House Joint Resolution 466 designates May as Amyotrophic Lateral Sclerosis (ALS) Awareness Month in Virginia, beginning in 2025 and continuing each year thereafter. The resolution is commemorative rather than regulatory: it recognizes ALS, also known as Lou Gehrig’s disease, as a progressive and fatal neurodegenerative disease and highlights the severe effects it has on patients and families.
The resolution emphasizes the lack of a known cure, the importance of research, clinical trials, assistive technologies, durable medical equipment, and access to new therapies for people living with ALS. It also notes the higher incidence of ALS among military veterans, the role of the ALS Association in funding research, and the 10th anniversary of the Ice Bucket Challenge as a major public-awareness and fundraising effort. The General Assembly directs the Clerk of the House to transmit the resolution to the ALS Association and post the designation on the legislature’s website.
Impact
HJR466 does not amend the Code of Virginia or create new legal duties, penalties, or funding requirements. Its practical effect is to establish an annual state-recognized observance in May and to place the General Assembly’s formal support behind ALS awareness, research, and advocacy efforts. The resolution may help elevate public attention to ALS and related issues affecting patients, caregivers, veterans, and medical-research stakeholders, but it does not change substantive state law.
Sentiment
The bill appears to have been received very positively and without opposition. It passed the House 96-0, was reported from Rules 15-0, and the Senate waived reading 39-0, indicating broad bipartisan support and little to no controversy. The tone of the resolution itself is sympathetic and supportive of patients, families, researchers, and advocacy organizations.
Contention
There is no notable recorded contention in the available materials, and no committee transcript indicates debate or disagreement. Because the measure is a ceremonial awareness resolution, any potential concerns would likely be limited to the general question of whether legislative time should be devoted to commemorative designations rather than policy changes, but no such objection appears in the voting history or bill text. The resolution’s references to military veterans, research funding, and access to therapies are supportive statements rather than disputed policy provisions.